PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study | PHASE SCIENTIFIC
PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer Screening Guang’an, Sichuan, September 20, 2025 – PHASE Scientific International Limited (“PHASE Scientific”) today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with the first site established in Guang’an, Sichuan Province, China. This study is led by Peking University Shenzhen Hospital, with participation from West China Guang’an Hospital of Sichuan University and technical and diagnostic support by PHASE Scientific. The study applies PHASE Scientific’s proprietary PHASiFY™ urine-based DNA concentration technology, aiming to explore a scalable, accessible approach to cervical cancer prevention that delivers next-level public health impact with scientific innovation. This prospective study plans to include 17,000 eligible women, evaluating the clinical performance of
PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study | PHASE SCIENTIFIC Skip to main content ENG ENG 繁體 简体 Share to Facebook Twitter LinkedIn Weibo WhatsApp WeChat Email Close Careers Media Centre Americas China Contact Us Hong Kong China Americas Home PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study Press Release September 22, 2025 PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer
Explore this link on the map →related reading
- B.C. physicians’ Pap-a-palooza like a ‘golden ticket’ for patients - Healthy Debatehealthydebate.ca
- Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
- HPV vaccine cutting cervical cancer by nearly 90%bbc.com
- Why don’t we screen healthy people to catch diseases early? | Out-Of-Pocketoutofpocket.health
- Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
- About Us | Papcup - Biosensor Technology Teampapcup.co.uk
- Home page | United States Preventive Services Taskforceuspreventiveservicestaskforce.org
- HPV and Cancer - NCIcancer.gov
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- US cancer death rate drops 33% since 1991, partly due to advances in treatment, early detection and less smoking, new report says | CNNedition.cnn.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org